Results 21 to 30 of about 11,284 (188)
Usefulness of anti -CCP antibodies in rheumatic diseases in Indian patients [PDF]
Indian Journal of Medical Sciences, 2009 The usefulness of anti-cyclic citrullinated peptide antibodies (anti-CCP antibodies) to identify rheumatic arthritis (RA) from other rheumatic diseases presenting with joint pain is not well studied.We aimed to determine the sensitivity and specificity of anti-CCP antibodies in Indian RA patients with respect to non-RA rheumatic diseases and to study ...
Gupta, R. +5 more
openaire +2 more sources
Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays [PDF]
Clinical Rheumatology, 2017 This study compares the diagnostic performance of a second generation anti-cyclic citrullinated peptide antibody (CCP2) with a third generation anti-CCP antibodies assay (CCP3), as well as the combination of both tests. Serum samples of 127 patients were analyzed.
Vos, I. +7 more
openaire +4 more sources
Viruses, 2021 COVID-19 convalescent plasma (CCP) is currently under investigation for both treatment and post-exposure prophylaxis. The active component of CCP mediating improved outcome is commonly reported as specific antibodies, particularly neutralizing antibodies,
Daniele Focosi +6 more
doaj +1 more source
Prevalence of anti-CCP antibodies in systemic sclerosis
Reumatismo, 2011 Joint involvement in systemic sclerosis (SSc) commonly occurs as arthralgias, while a true arthritis is less frequent. The most common arthritis developing in SSc is rheumatoid arthritis (RA) and its diagnosis may be misled by concomitant joint contracture or tendon sheath involvement due to SSc.
MARRONE M +8 more
openaire +6 more sources
Indian Journal of Ophthalmology, 2020 Patients with moderate to severe dry eyes are often screened at the Dry Eye Clinic to rule out connective tissue diseases. Rheumatoid factor (RF) is one of the screening tools to rule out rheumatoid arthritis (RA).
Prabhakar Singh +2 more
doaj +1 more source
Anti‐CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis
Annals of the New York Academy of Sciences, 2008 Rheumatoid arthritis (RA) is a common autoimmune disease characterized by chronic inflammation of synovial joints. In most cases this will lead to the formation of pannus tissue, ultimately leading to joint destruction. Early diagnosis, coupled with aggressive use of disease‐modifying antirheumatic drugs, has been shown to have a favorable effect on ...
Venrooij, W.J.W. van +2 more
openaire +4 more sources
P01-019 – Anti-CCP antibodies are not associated with FMF [PDF]
Pediatric Rheumatology, 2013 Familial Mediterranean Fever (FMF) is an autosomal recessive disease that is prevalent among eastern Mediterranean populations, mainly non-Ashkenazi Jews, Armenians, Turks, and Arabs. Arthritis seen in FMF patients is generally acute monoarthritis which predominantly affecting the lower limbs, and it occurs during attack periods and also is a common ...
Onur, H +5 more
openaire +1 more source
The Clinical Utility of Autoantibodies in Patients with Idiopathic Granulomatous Mastitis
Journal of Investigative Surgery, 2022 Background Although the etiopathogenesis of idiopathic granulomatous mastitis (IGM) is still controversial, recently autoimmunity and immune dysregulation have been emphasized.
Hande Koksal
doaj +1 more source
Mediators of Inflammation, 2007 Anti-cyclic citrullinated peptide (CCP) antibody is a useful marker for the diagnosis and prognosis of rheumatoid arthritis (RA). Recently, clinical significance of follow-up in anti-CCP antibody titer has been pointed out.
Toshiaki Kogure +4 more
doaj +1 more source
Reumatismo, 2011 Objective: To assess the role of anti-cyclic citrullinated peptide (CCP) antibody detection in synovial fluid (SF) of RA patients compared to OA patients.
G. Valesini +4 more
doaj +1 more source